"I'm definitely not in the camp of 'absolutely would not prescribe.' I think this medication has a lot of potential benefits," said Leena P Mittal, MD, chief of the Division of Women's Mental Health, Brigham and Women's Hospital, Boston, Massachusetts. But "there is still a lot of information that is yet to be known or clarified in terms of how and to whom we prescribe this medication."
"If cost is a barrier, you could widen disparities to a clinical problem that already disproportionately affects people who have less access to traditional treatments like therapy," said Kirstin E Leitner, MD, assistant professor of Clinical Obstetrics and Gynecology, Penn Medicine, Philadelphia.
"Sage and Biogen plan to have support services and financial assistance programs available" for patients who meet certain requirements, Henson said. "Coverage across all payor segments traditionally ta
[
add
]
[
|
|
...
]